Abstract
Described are pharmaceutical formulations comprising naltrexone and/or bupropion. Such pharmaceutical formulations can comprise extended-release, multilayer beads. Also described are methods of administering such formulations, such as for the treatment of overweight or obesity.
Full Text
What is claimed is:
Described are pharmaceutical formulations comprising naltrexone and/or bupropion. Such pharmaceutical formulations can comprise extended-release, multilayer beads. Also described are methods of administering such formulations, such as for the treatment of overweight or obesity.
Timeline
Filed
04/13/2026Published
08/13/2026Granted
Not AvailableIPC Codes(4)
A61K 9/20:Pills, lozenges or tablets
A61K 9/00:Medicinal preparations characterised by special physical form
A61K 31/137:Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine